Juan Jesús
Gómez-Reino Carnota
Radboud University Nijmegen Medical Centre
Nimega, HolandaPublicacións en colaboración con investigadores/as de Radboud University Nijmegen Medical Centre (8)
2016
-
Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: Data from the CERERRA collaboration
Arthritis Research and Therapy, Vol. 18, Núm. 1
-
Erratum to: Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: Data from the CERERRA collaboration [Arthritis Res Ther. 18: (2016); 50], doi: 10.1186/s13075-016-0951-z
Arthritis Research and Therapy
2012
-
Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: Results of a 1-year follow-up study from the CERERRA collaboration
Annals of the Rheumatic Diseases, Vol. 71, Núm. 3, pp. 374-377
2011
-
Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: Pooled data from 10 European registries
Annals of the Rheumatic Diseases, Vol. 70, Núm. 9, pp. 1575-1580
2010
-
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
Annals of the Rheumatic Diseases, Vol. 69, Núm. 6, pp. 964-975
2008
-
Methods of deriving EULAR/ACR recommendations on reporting disease activity in clinical trials of patients withd-heumatoid arthritis
Annals of the Rheumatic Diseases, Vol. 67, Núm. 10, pp. 1365-1373
-
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations
Annals of the Rheumatic Diseases, Vol. 67, Núm. 10, pp. 1360-1364
-
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations
Arthritis Care and Research, Vol. 59, Núm. 10, pp. 1371-1377